MedPath

Urapidil

Generic Name
Urapidil
Drug Type
Small Molecule
Chemical Formula
C20H29N5O3
CAS Number
34661-75-1
Unique Ingredient Identifier
A78GF17HJS

Overview

Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.

Indication

用于治疗高血压;尚可用于良性前列腺增生肥大;注射剂主要用于术中高血压危象。

Associated Conditions

  • Hypertension
  • Hypertensive Emergency

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/10/10
N/A
Not yet recruiting
Qianfoshan Hospital
2019/01/02
Phase 3
Completed
The George Institute for Global Health, China
2018/04/13
Not Applicable
Completed
Chinese PLA General Hospital
2017/10/03
Phase 4
Withdrawn
2016/12/23
Phase 1
UNKNOWN
2016/08/05
Not Applicable
UNKNOWN
Hu Anmin
2015/09/23
Phase 3
Terminated
University Hospital, Strasbourg, France
2011/03/09
Not Applicable
Withdrawn
University Hospital Schleswig-Holstein
2006/12/08
Phase 3
UNKNOWN
University Hospital, Strasbourg, France
2005/09/26
Not Applicable
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.